← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Kamuzu University Of Health Sciences
Blantyre
$3,221,663
Total funding
9
Grants
Funding over time
peak $2.5M · FY2023–25$2.5M$1.9M$1.3M$625K$0
'23
'24
'25
Funding mix
By agency
NIH$3,221,663 · 9
By mechanism
U19$1,554,926 · 4
R25$878,175 · 2
D43$570,842 · 2
K43$217,720 · 1
Investigators at Kamuzu University Of Health Sciences
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Accelerating malaria prevention through enhanced analysis of transmission and RTS,S vaccination in Malawi$800,270
U19 · FY2024 · AI
Accelerating malaria prevention through enhanced analysis of transmission and RTS,S vaccination in Malawi$754,657
U19 · FY2025 · AI
CAPACITY BUILDING FOR HEALTH PROFESSION EDUCATION AND RESEARCH IN MALAWI (CHEER-MALAWI)$599,963
R25 · FY2023 · TW
Administrative Core$349,894
U19 · FY2024 · AI
Malawi HIV Implementation Research Scientist Training Program (MHIRST)$304,400
D43 · FY2025 · TW
DIRECT: Enhancing Bioethics Capacities at Kamuzu University of Health Sciences (KUHeS)$278,212
R25 · FY2025 · TW
Malawian Program for Mental Health Research Training (WARMHEART)$266,442
D43 · FY2025 · TW
Epidemiology$230,019
U19 · FY2025 · AI
Administrative Core$204,192
U19 · FY2025 · AI
Transmission$188,537
U19 · FY2025 · AI
Transmission$156,991
U19 · FY2024 · AI
Epidemiology$150,980
U19 · FY2024 · AI
Data Management & Biostatistics Core$142,404
U19 · FY2024 · AI
Data Management & Biostatistics Core$131,909
U19 · FY2025 · AI
Informing optimal dosing of the future antimalarial, artemether-lumefantrine plus amodiaquine, in key neglected target populations of children with severe acute malnutrition and adults living with HIV$108,916
K43 · FY2024 · TW
Informing optimal dosing of the future antimalarial, artemether-lumefantrine plus amodiaquine, in key neglected target populations of children with severe acute malnutrition and adults living with HIV$108,804
K43 · FY2025 · TW